Bisphosphonate Therapy in Children with Secondary Osteoporosis

被引:6
|
作者
Papapoulos, Socrates E. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, NL-2333 ZA Leiden, Netherlands
来源
HORMONE RESEARCH IN PAEDIATRICS | 2011年 / 76卷
关键词
Children; Bisphosphonates; Fractures; Secondary osteoporosis; OSTEOGENESIS-IMPERFECTA; FRACTURES; PAMIDRONATE; ADOLESCENTS; RISK;
D O I
10.1159/000329151
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Increased bone fragility requiring effective treatments is a complication of various chronic conditions in children. Bisphosphonates, highly effective in the treatment of adults with osteoporosis, have also been used in children with secondary osteoporosis. However, results obtained in adults cannot be readily extrapolated to children due to differences in the pathophysiology and progression of the disease as well as in the pharmacokinetics of bisphosphonates. Conclusions: Available results of studies of bisphosphonates in children with secondary osteoporosis do not yet support their recommendation as standard therapy. Their use should be restricted to patients with fragility fractures and low bone mass. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:24 / 27
页数:4
相关论文
共 50 条
  • [31] Efficiency of intravenous bisphosphonate therapy in patients with osteoporosis.
    Steindorf, J
    Relke, B
    Boesel, I
    Heberling, HJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S405 - S405
  • [32] Continuation of Bisphosphonate Therapy for Osteoporosis beyond 5 Years
    Chang, Leslie L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (15): : 1467 - 1469
  • [33] Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday
    McClung, Michael
    Harris, Steven T.
    Miller, Paul D.
    Bauer, Douglas C.
    Davison, K. Shawn
    Dian, Larry
    Hanley, David A.
    Kendler, David L.
    Yuen, Chui Kin
    Lewiecki, E. Michael
    AMERICAN JOURNAL OF MEDICINE, 2013, 126 (01): : 13 - 20
  • [34] Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday
    Sanchez, Ariel
    ACTUALIZACIONES EN OSTEOLOGIA, 2013, 9 (01) : 102 - 103
  • [35] Bisphosphonate Therapy for Osteoporosis A Potential Risk for Subtrochanteric Fractures
    Watters, Carol
    ORTHOPAEDIC NURSING, 2010, 29 (03) : 210 - 213
  • [36] OSTEOPOROSIS IN 2011 Osteoporosis therapy-dawn of the post-bisphosphonate era
    Baron, Roland
    NATURE REVIEWS ENDOCRINOLOGY, 2012, 8 (02) : 76 - 78
  • [37] Integral dental treatment in patient with osteoporosis secondary to hypothyroidism prior to therapy with bisphosphonate: case report and literature review
    Zuniga Araya, Minor Enrique
    Ayala Herrera, Jose Luis
    Martinez Martinez, Rita Elizabeth
    Olvera Delgado, Jose Honorio
    Garrigos Portales, Denisse
    CLINICAL CASES IN MINERAL AND BONE METABOLISM, 2018, 15 (02) : 288 - 293
  • [38] Bisphosphonate therapy for massive osteolytic secondary neoplasms
    Kumta, SM
    Quintos, AD
    Griffith, JF
    Choi, PHK
    Chow, LTC
    Leung, PC
    BONE, 2002, 30 (03) : 51S - 51S
  • [39] Expanding role of bisphosphonate therapy in children
    Shoemaker, LR
    JOURNAL OF PEDIATRICS, 1999, 134 (03): : 264 - 267
  • [40] Bisphosphonate use in children with pediatric osteoporosis and other bone conditions
    Szalay, Elizabeth A.
    JOURNAL OF PEDIATRIC REHABILITATION MEDICINE, 2014, 7 (02) : 125 - 132